🇺🇸 Epsilon Aminocaproic Acid in United States

16 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Respiratory Distress Syndrome — 2 reports (12.5%)
  2. Coagulopathy — 2 reports (12.5%)
  3. Colon Gangrene — 2 reports (12.5%)
  4. Intestinal Infarction — 2 reports (12.5%)
  5. Procedural Complication — 2 reports (12.5%)
  6. Renal Failure — 2 reports (12.5%)
  7. Abdominal Discomfort — 1 report (6.25%)
  8. Abdominal Distension — 1 report (6.25%)
  9. Adrenal Suppression — 1 report (6.25%)
  10. Angioedema — 1 report (6.25%)

Source database →

Epsilon Aminocaproic Acid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Epsilon Aminocaproic Acid approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Epsilon Aminocaproic Acid in United States?

Wake Forest University Health Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.